Effectiveness of zuclopenthixol compared with haloperidol in the treatment of behavioural disturbances in learning disabled patients
- PMID: 7788130
- DOI: 10.1192/bjp.166.3.374
Effectiveness of zuclopenthixol compared with haloperidol in the treatment of behavioural disturbances in learning disabled patients
Abstract
Background: We compared the efficacy of two neuroleptics with different receptor profiles (zuclopenthixol and haloperidol) in learning disabled patients with behavioural disturbance.
Method: A double-blind crossover study (2 x 8 weeks; n = 34), interrupted by a two-week single-blind washout period, was employed. Assessments included the Schedule for Handicaps, Behaviour, and Skills (SHBS) and Clinical Global Impression (CGI).
Results: The SHBS score was significantly reduced for the zuclopenthixol cohort only. End-point analysis between the two drugs also showed an enhanced effect for zuclopenthixol over haloperidol. CGI scores did not reveal significant differences between the two drugs.
Conclusion: Zuclopenthixol may be superior to haloperidol for the treatment of behavioural disturbances in mentally retarded subjects.
Similar articles
-
Zuclopenthixol and haloperidol in patients with acute psychotic states. A double-blind, multi-centre study.Curr Med Res Opin. 1992;12(9):594-603. doi: 10.1185/03007999209111526. Curr Med Res Opin. 1992. PMID: 1582239 Clinical Trial.
-
A double-blind comparison of zuclopenthixol tablets with placebo in the treatment of mentally handicapped in-patients with associated behavioural disorders.J Intellect Disabil Res. 1992 Dec;36 ( Pt 6):541-9. doi: 10.1111/j.1365-2788.1992.tb00572.x. J Intellect Disabil Res. 1992. PMID: 1477491 Clinical Trial.
-
A double blind comparison of zuclopenthixol acetate with haloperidol in the management of acutely disturbed schizophrenics.Med J Malaysia. 1998 Dec;53(4):365-71. Med J Malaysia. 1998. PMID: 10971979 Clinical Trial.
-
Zuclopenthixol and haloperidol/levomepromazine in the treatment of elderly patients with symptoms of aggressiveness and agitation: a double-blind, multi-centre study.Pharmatherapeutica. 1989;5(5):285-91. Pharmatherapeutica. 1989. PMID: 2568639 Clinical Trial.
-
Neuroleptic treatment of oligophrenic patients. A double-blind clinical multicentre trial of cis(Z)-clopenthixol and haloperidol.Acta Psychiatr Scand Suppl. 1981;294:39-45. Acta Psychiatr Scand Suppl. 1981. PMID: 7041518 Clinical Trial.
Cited by
-
Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses.Cochrane Database Syst Rev. 2012 Apr 18;2012(4):CD000525. doi: 10.1002/14651858.CD000525.pub3. Cochrane Database Syst Rev. 2012. PMID: 22513898 Free PMC article.
-
Psychopharmacological treatments in persons with dual diagnosis of psychiatric disorders and developmental disabilities.Postgrad Med J. 2003 Mar;79(929):139-46. doi: 10.1136/pmj.79.929.139. Postgrad Med J. 2003. PMID: 12697912 Free PMC article. Review.
-
Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders.Cochrane Database Syst Rev. 2015 Jan 16;1(1):CD009831. doi: 10.1002/14651858.CD009831.pub2. Cochrane Database Syst Rev. 2015. PMID: 25592299 Free PMC article.
-
Zuclopenthixol dihydrochloride for schizophrenia.Cochrane Database Syst Rev. 2017 Nov 16;11(11):CD005474. doi: 10.1002/14651858.CD005474.pub2. Cochrane Database Syst Rev. 2017. PMID: 29144549 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
